Gender-specific association between the kininogen 1 gene variants and essential hypertension in Chinese Han population

Journal of Hypertension

Volumn 27, Issue 3, 2009, Pages 484-490

  Zhao, Weiyan ^a,b   Wang, Yaping ^a   Wang, Laiyuan ^a   Lu, Xiangfeng ^a   Yang, Wei ^a   Huang, Jianfeng ^a   Chen, Shufeng ^a   Gu, Dongfeng ^a,b  

^a FUWAI HOSPITAL   (China)

^b CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

Author keywords

Case control study; Essential hypertension; Haplotype; Kininogen 1 gene; Tagging SNP

Indexed keywords

GENOMIC DNA; KININOGEN; KININOGEN I; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CHINA; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 67649543777     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32831e19f9     Document Type: Article

References (35)

1. Schneider EG, Strandhoy JW, Willis LR, Knox FG. Relationship between proximal sodium reabsorption and excretion of calcium, magnesium and phosphate. Kidney Int 1973; 4:369-376.
2. Campbell DJ. The kallikrein-kinin system in humans. Clin Exp Pharmacol Physiol 2001; 28:1060-1065.
3. Colman RW, Schmaier AH. Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. Blood 1997; 90:3819-3843.
4. Damas J. The brown Norway rats and the kinin system. Peptides 1996; 17:859-872.
5. Majima M, Yoshida O, Mihara H, Muto T, Mizogami S, Kuribayashi Y, Katori M. High sensitivity to salt in kininogen-deficient brown Norway Katholiek rats. Hypertension 1993; 22:705-714.
6. Kitamura N, Kitagawa H, Fukushima D, Takagaki Y, Miyata T, Nakanishi S. Structural organization of the human kininogen gene and a model for its evolution. J Biol Chem 1985; 260:8610-8617.
7. Fong D, Smith DI, Hsieh WT. The human kininogen gene (KNG) mapped to chromosome 3q26-qter by analysis of somatic cell hybrids using the polymerase chain reaction. Hum Genet 1991; 87:189-192.
8. Cheung PP, Cannizzaro LA, ColmanRW. Chromosomal mapping ofhuman kininogen gene (KNG) to 3q26 - qter. Cytogenet Cell Genet 1992; 59:24-26.
9. Rizzu P, Baldini A. Three members of the human cystatin gene superfamily, AHSG, HRG, and KNG, map within one megabase of genomic DNA at 3q27. Cytogenet Cell Genet 1995; 70:26-28.
10. Vionnet N, Tregouet D, Kazeem G, Gut I, Groop PH, Tarnow L, Parving HH. Analysis of 14 candidate genes for diabetic nephropathy on chromosome 3q in European populations: strongest evidence for association with a variant in the promoter region of the adiponectin gene. Diabetes 2006; 55:3166-3174.
11. Rhaleb NE, Yang XP, Nanba M, Shesely EG, Carretero OA. Effect of chronic blockade of the kallikrein-kinin system on the development of hypertension in rats. Hypertension 2001; 37:121-128.
12. Oza NB, Schwartz JH, Goud HD, Levinsky NG. Rat aortic smooth muscle cells in culture express kallikrein, kininogen, and bradykininase activity. J Clin Invest 1990; 85:597-600.
13. Nothnagel M, Rohde K. The effect of single-nucleotide polymorphism marker selection on patterns of haplotype blocks and haplotype frequency estimates. Am J Hum Genet 2005; 77:988-998.
14. Hao K, Liu S, Niu T. A sparse marker extension tree algorithm for selecting the best set of haplotype tagging single nucleotide polymorphisms. Genet Epidemiol 2005; 29:336-352.
15. Deloukas P, Bentley D. The HapMap project and its application to genetic studies of drug response. Pharmacogenomics J 2004; 4:88-90.
16. Schmidt CW. HapMap: building a database with blocks. EHP Toxicogenomics 2003; 111:A16.
17. Gu D, Reynolds K, Wu X, Chen J, Duan X, Muntner P, Huang G. Prevalence, awareness, treatment, and control of hypertension in china. Hypertension 2002; 40:920-927.
18. Levy D, DeStefano AL, Larson MG, O'Donnell CJ, Lifton RP, Gavras H, Cupples LA. Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the Framingham heart study. Hypertension 2000; 36:477-483.
19. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21:263-265.
20. Chapman JM, Cooper JD, Todd JA, Clayton DG. Detecting disease associations due to linkage disequilibrium using haplotype tags: a class of tests and the determinants of statistical power. Hum Hered 2003; 56:18-31.
21. Benjamini Y, Hochberg Y. The control of the false discovery rate in multiple testing under dependency. Ann Stat 2001; 29:1165-1188.
22. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002; 70:425-434.
23. Lake SL, LyonH, TantisiraK,Silverman EK, Weiss ST, Laird NM, Schaid DJ. Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered 2003; 55:56-65.
24. Margolius HS. Theodore Cooper Memorial Lecture. Kallikreins and kinins. Some unanswered questions about system characteristics and roles in human disease. Hypertension 1995; 26:221-229.
25. Dasgupta K, O'Loughlin J, Chen S, Karp I, Paradis G, Tremblay J, Hamet P. Emergence of sex differences in prevalence of high systolic blood pressure: analysis of a longitudinal adolescent cohort. Circulation 2006; 114:2663- 2670.
26. Wolf-MaierK, CooperRS, Banegas JR, GiampaoliS,Hense HW, Joffres M, Kastarinen M. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003; 289:2363- 2369.
27. Martins D, Nelson K, Pan D, Tareen N, Norris K. The effect of gender on age-related blood pressure changes and the prevalence of isolated systolic hypertension among older adults: data from NHANES III. J Gend Specif Med 2001; 4:10-13; 20.
28. Wang S, Yehya N, Schadt EE, Wang H, Drake TA, Lusis AJ. Genetic and genomic analysis of a fat mass trait with complex inheritance reveals marked sex specificity. PLoS Genet 2006; 2:e15.
29. Yang X, Schadt EE, Wang S, Wang H, Arnold AP, Ingram-Drake L, Drake TA. Tissue-specific expression and regulation of sexually dimorphic genes in mice. Genome Res 2006; 16:995-1004.
30. Chen LM, Chung P, Chao S, Chao L, Chao J. Differential regulation of kininogen gene expression by estrogen and progesterone in vivo. Biochim Biophys Acta 1992; 1131:145-151.
31. Cheung PP, Kunapuli SP, Scott CF, Wachtfogel YT, Colman RW. Genetic basis of total kininogen deficiency in Williams' trait. J Biol Chem 1993; 268:23361-23365.
32. Jiang YP, Muller-EsterlW,Schmaier AH. Domain3 of kininogens contains a cell-binding site and a site that modifies thrombin activation of platelets. J Biol Chem 1992; 267:3712-3717.
33. Weisel JW, Nagaswami C, Woodhead JL, DeLa Cadena RA, Page JD, Colman RW. The shape of high molecular weight kininogen. Organization into structural domains, changes with activation, and interactions with prekallikrein, as determined by electron microscopy. J Biol Chem 1994; 269:10100- 10106.
34. Huang Q, Fu YX, Boerwinkle E. Comparison of strategies for selecting single nucleotide polymorphisms for case/control association studies. Hum Genet 2003; 113:253-257.
35. Risch NJ. Searching for genetic determinants in the new millennium. Nature 2000; 405:847-856.